Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Days Payable: 101.91 (As of Dec. 2025) — 23% Below Median


MIL:ERFO Laboratorio Farmaceutico Erfo SpA MIL:ERFO
68 GF Score
Price €1.18
GF Value €2.10
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Laboratorio Farmaceutico Erfo SpA Days Payable?

Laboratorio Farmaceutico Erfo SpA MIL:ERFO +0.85% 68 Days Payable is 101.91 as of Dec. 2025, which is 23% below its 10-year median of 132.38. GuruFocus rates MIL:ERFO with a GF Score™ of 68/100 and a GF Value™ of €2.10 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,881 Consumer Packaged Goods companies, Laboratorio Farmaceutico Erfo SpA ranks better than 78.84% on this metric.

Laboratorio Farmaceutico Erfo SpA's average Accounts Payable for the six months ended in Dec. 2025 was €0.73 Mil. Laboratorio Farmaceutico Erfo SpA's Cost of Goods Sold for the six months ended in Dec. 2025 was €1.31 Mil. Hence, Laboratorio Farmaceutico Erfo SpA's Days Payable for the six months ended in Dec. 2025 was 101.91.

The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's Days Payable or its related term are showing as below:

MIL:ERFO' s Days Payable Range Over the Past 10 Years
Min: 86.38   Med: 132.38   Max: 148.07
Current: 86.38

During the past 7 years, Laboratorio Farmaceutico Erfo SpA's highest Days Payable was 148.07. The lowest was 86.38. And the median was 132.38.

MIL:ERFO's Days Payable is ranked better than
78.84% of 1881 companies
in the Consumer Packaged Goods industry
Industry Median: 44.14 vs MIL:ERFO: 86.38

Laboratorio Farmaceutico Erfo SpA's Days Payable declined from Dec. 2024 (151.07) to Dec. 2025 (101.91). It may suggest that Laboratorio Farmaceutico Erfo SpA accelerated paying its suppliers.


Laboratorio Farmaceutico Erfo SpA Days Payable Related Terms


Laboratorio Farmaceutico Erfo SpA Days Payable Historical Data

* Premium members only.

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Farmaceutico Erfo SpA Days Payable Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 96.98 148.07 137.26 132.38 87.06

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 147.51 137.03 151.07 73.26 101.91

MIL:ERFO vs KHC, GIS, HRL: Days Payable Comparison

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Farmaceutico Erfo SpA Days Payable vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's Days Payable distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's Days Payable falls into.


MIL:ERFO
68GF Score
Laboratorio Farmaceutico Erfo SpA MIL:ERFO
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Farmaceutico Erfo SpA Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Laboratorio Farmaceutico Erfo SpA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.623 + 0.779) / 2 ) / 2.939*365
=0.701 / 2.939*365
=87.06

Laboratorio Farmaceutico Erfo SpA's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.684 + 0.779) / 2 ) / 1.31*365 / 2
=0.7315 / 1.31*365 / 2
=101.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 101.91 mean?
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a Days Payable of 101.91 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. This is 23% below median its historical median of 132.38. Over the past decade, Laboratorio Farmaceutico Erfo SpA's Days Payable has ranged from 86.38 to 148.07. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #398 out of 1881 companies in the Consumer Packaged Goods industry, placing it in the top 21.2%.
Is Laboratorio Farmaceutico Erfo SpA's Days Payable too high?
Laboratorio Farmaceutico Erfo SpA's current Days Payable of 101.91 is 23% below median its 10-year median of 132.38. Over the past 10 years, this metric has ranged from a low of 86.38 to a high of 148.07. The Consumer Packaged Goods industry median Days Payable is 44.14. Laboratorio Farmaceutico Erfo SpA's value of 101.91 is 130.9% above this industry median. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #398 out of 1881 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's Days Payable compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #398 out of 1881 companies for Days Payable. This places Laboratorio Farmaceutico Erfo SpA in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.14. Laboratorio Farmaceutico Erfo SpA's value of 101.91 is 130.9% above this benchmark. Historically, Laboratorio Farmaceutico Erfo SpA's own Days Payable has ranged from 86.38 to 148.07 over the past decade. While the company's 10-year median is 132.38 vs. the industry median of 44.14, Laboratorio Farmaceutico Erfo SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.14, based on 1,881 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Farmaceutico Erfo SpA's current Days Payable of 101.91 is 130.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current Days Payable is 101.91, which is 23% below median its own 10-year median of 132.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.10, compared to a current price of €1.18 — trading 43.8% below its estimated fair value. The current Days Payable is 101.91, which is 23% below median its 10-year median of 132.38 and 130.9% above the Consumer Packaged Goods industry median of 44.14. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current Days Payable is 101.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued. The current stock price of €1.18 is trading 43.8% below its estimated GF Value™ of €2.10. GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.

Key valuation signals for MIL:ERFO:

  • Days Payable: 101.91 (23% below median its 10-year median of 132.38)
  • GF Value™: €2.10 vs. price of €1.18 (43.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs
  • Industry Position: 130.9% above the Consumer Packaged Goods median (#398 of 1881)

No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Farmaceutico Erfo SpA Business Description

Address Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
68GF Score

Get the complete analysis for MIL:ERFO

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.18
Price
€2.10
GF Value